Diabetes Care, Vol 22, Issue 2 262-270, Copyright © 1999 by American Diabetes Association

ARTICLES

Fasting proinsulin concentrations predict the development of type 2 diabetes

NJ Wareham, CD Byrne, R Williams, NE Day and CN Hales
Department of Community Medicine, University of Cambridge, England, U.K. njw1004@medschl.cam.ac.uk

OBJECTIVE: The development of specific assays allows the different molecules in the proinsulin processing pathway to be measured separately. 32,33 Split proinsulin is the predominant form of proinsulin and accounts for the disproportionate hyperproinsulinemia seen in individuals with prevalent type 2 diabetes. This study was established to examine whether the concentration of this molecule predicts diabetes. RESEARCH DESIGN AND METHODS: A population-based longitudinal cohort study was conducted in Ely, Cambridgeshire. At baseline, 1,122 individuals completed a 75-g oral glucose tolerance test (OGTT). At the 4.5-year follow-up study, repeat OGTTs were performed on 937 of the cohort of 1,071 individuals who had been nondiabetic at baseline. RESULTS: A total of 26 people progressed to diabetes as determined by the OGTTs. The risk of progression was strongly related to the fasting glucose concentration (relative risk [RR] comparing top with bottom quartile 17.6 [95% CI 2.4-130.4]) and fasting 32,33 split proinsulin (RR 16.4 [2.2-121.9]), but less strongly to the fasting insulin (RR 4.41 [1.5-12.9]) or intact proinsulin (RR 5.2 [1.5-17.3]). In multivariate analyses, these associations were independent of age, sex, BMI, and baseline glucose tolerance category. Subjects in the top quartile for fasting glucose and total proinsulin with a family history of diabetes were a high-risk subgroup (incidence 65.8 per 1,000 person-years of follow-up [pyfu]); 30% of them progressed to diabetes at follow-up. CONCLUSIONS: Fasting 32,33 split proinsulin independently predicts the development of diabetes. This prediction was better than that observed for either the insulin or intact proinsulin concentrations. The combination of family history, fasting glucose, and total proinsulin identified a subgroup of individuals at high risk of progression who might benefit from targeted interventions.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. G. Forouhi, J. Luan, A. Cooper, B. J. Boucher, and N. J. Wareham Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance: The Medical Research Council Ely Prospective Study 1990-2000 Diabetes, October 1, 2008; 57(10): 2619 - 2625. [Abstract] [Full Text] [PDF]

				U. Ekelund, S. Brage, H. Besson, S. Sharp, and N. J Wareham Time spent being sedentary and weight gain in healthy adults: reverse or bidirectional causality? Am. J. Clinical Nutrition, September 1, 2008; 88(3): 612 - 617. [Abstract] [Full Text] [PDF]

				M. Rahman, R. K Simmons, A.-H. Harding, N. J Wareham, and S. J Griffin A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study Fam. Pract., June 1, 2008; 25(3): 191 - 196. [Abstract] [Full Text] [PDF]

				C. L Gillies, P. C Lambert, K. R Abrams, A. J Sutton, N. J Cooper, R. T Hsu, M. J Davies, and K. Khunti Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis BMJ, May 24, 2008; 336(7654): 1180 - 1185. [Abstract] [Full Text] [PDF]

				S. Valdes, P. Botas, E. Delgado, F. Alvarez, and F. D. Cadorniga Population-Based Incidence of Type 2 Diabetes in Northern Spain: The Asturias Study Diabetes Care, September 1, 2007; 30(9): 2258 - 2263. [Abstract] [Full Text] [PDF]

				R. K. Semple, N. H. Halberg, K. Burling, M. A. Soos, T. Schraw, J. Luan, E. K. Cochran, D. B. Dunger, N. J. Wareham, P. E. Scherer, et al. Paradoxical Elevation of High-Molecular Weight Adiponectin in Acquired Extreme Insulin Resistance Due to Insulin Receptor Antibodies Diabetes, June 1, 2007; 56(6): 1712 - 1717. [Abstract] [Full Text] [PDF]

				K. Tan, W. A. Kimber, J. Luan, M. A. Soos, R. K. Semple, N. J. Wareham, S. O'Rahilly, and I. Barroso Analysis of Genetic Variation in Akt2/PKB-{beta} in Severe Insulin Resistance, Lipodystrophy, Type 2 Diabetes, and Related Metabolic Phenotypes Diabetes, March 1, 2007; 56(3): 714 - 719. [Abstract] [Full Text] [PDF]

				J. L. Mesa, R. J.F. Loos, P. W. Franks, K. K. Ong, J. Luan, S. O'Rahilly, N. J. Wareham, and I. Barroso Lamin A/C Polymorphisms, Type 2 Diabetes, and the Metabolic Syndrome: Case-Control and Quantitative Trait Studies Diabetes, March 1, 2007; 56(3): 884 - 889. [Abstract] [Full Text] [PDF]

				R. J. F. Loos, I. Barroso, S. O'Rahilly, and N. J. Wareham Comment on "A Common Genetic Variant Is Associated with Adult and Childhood Obesity" Science, January 12, 2007; 315(5809): 187c - 187c. [Abstract] [Full Text] [PDF]

				A. Al-Zahrani, M. S. Sandhu, R. N. Luben, D. Thompson, C. Baynes, K. A. Pooley, C. Luccarini, H. Munday, B. Perkins, P. Smith, et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer Hum. Mol. Genet., January 1, 2006; 15(1): 1 - 10. [Abstract] [Full Text] [PDF]

				W. Hardeman, S. Sutton, S. Griffin, M. Johnston, A. White, N. J. Wareham, and A. L. Kinmonth A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation Health Educ. Res., December 1, 2005; 20(6): 676 - 687. [Abstract] [Full Text] [PDF]

				P. W. Franks, J. Luan, I. Barroso, S. Brage, J. L. G. Sanchez, U. Ekelund, M. S. Rios, A. J. Schafer, S. O'Rahilly, and N. J. Wareham Variation in the eNOS Gene Modifies the Association Between Total Energy Expenditure and Glucose Intolerance Diabetes, September 1, 2005; 54(9): 2795 - 2801. [Abstract] [Full Text] [PDF]

				M. S. Sandhu, B. Heude, E. H. Young, R. Luben, J. Luan, K.-T. Khaw, J. Todd, and N. J. Wareham INS VNTR Class Genotype and Indexes of Body Size and Obesity: Population-Based Studies of 7,999 Middle-Aged Men and Women Diabetes, September 1, 2005; 54(9): 2812 - 2815. [Abstract] [Full Text] [PDF]

				U. Ekelund, S. Brage, P. W Franks, S. Hennings, S. Emms, M.-Y. Wong, and N. J Wareham Physical activity energy expenditure predicts changes in body composition in middle-aged healthy whites: effect modification by age Am. J. Clinical Nutrition, May 1, 2005; 81(5): 964 - 969. [Abstract] [Full Text] [PDF]

				R. K. Semple, J. C. Achermann, J. Ellery, I. S. Farooqi, F. E. Karet, R. G. Stanhope, S. O'Rahilly, and S. A. Aparicio Two Novel Missense Mutations in G Protein-Coupled Receptor 54 in a Patient with Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1849 - 1855. [Abstract] [Full Text] [PDF]

				K. Kaushal, A. H. Heald, K. W. Siddals, M. S. Sandhu, D. B. Dunger, J. M. Gibson, and N. J. Wareham The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome Diabetes Care, November 1, 2004; 27(11): 2682 - 2688. [Abstract] [Full Text] [PDF]

				C.-C. Connie Hung, F. Pirie, J. Luan, E. Lank, A. Motala, G. S.H. Yeo, J. M. Keogh, N. J. Wareham, S. O'Rahilly, and I. S. Farooqi Studies of the Peptide YY and Neuropeptide Y2 Receptor Genes in Relation to Human Obesity and Obesity-Related Traits Diabetes, September 1, 2004; 53(9): 2461 - 2466. [Abstract] [Full Text] [PDF]

				B. Zethelius, C. N. Hales, H. O. Lithell, and C. Berne Insulin Resistance, Impaired Early Insulin Response, and Insulin Propeptides as Predictors of the Development of Type 2 Diabetes: A population-based, 7-year follow-up study in 70-year-old men Diabetes Care, June 1, 2004; 27(6): 1433 - 1438. [Abstract] [Full Text] [PDF]

				P. W. Franks, U. Ekelund, S. Brage, M.-Y. Wong, and N. J. Wareham Does the Association of Habitual Physical Activity With the Metabolic Syndrome Differ by Level of Cardiorespiratory Fitness? Diabetes Care, May 1, 2004; 27(5): 1187 - 1193. [Abstract] [Full Text] [PDF]

				F. Bacha, R. Saad, N. Gungor, and S. A. Arslanian Adiponectin in Youth: Relationship to visceral adiposity, insulin sensitivity, and {beta}-cell function Diabetes Care, February 1, 2004; 27(2): 547 - 552. [Abstract] [Full Text] [PDF]

				M. S. Sandhu, J. M. Gibson, A. H. Heald, D. B. Dunger, and N. J. Wareham Association between Insulin-Like Growth Factor-I: Insulin-Like Growth Factor-Binding Protein-1 Ratio and Metabolic and Anthropometric Factors in Men and Women Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 166 - 170. [Abstract] [Full Text] [PDF]

				M. Maliqueo, I. Atwater, R. Lahsen, F. Perez-Bravo, B. Angel, and T. Sir-Petermann Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of {beta}-cell dysfunction? Hum. Reprod., December 1, 2003; 18(12): 2683 - 2688. [Abstract] [Full Text] [PDF]

				M. E. Silfen, M. R. Denburg, A. M. Manibo, R. A. Lobo, R. Jaffe, M. Ferin, L. S. Levine, and S. E. Oberfield Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4682 - 4688. [Abstract] [Full Text] [PDF]

				P. W. Franks, I. S. Farooqi, J.'a. Luan, M.-Y. Wong, I. Halsall, S. O'Rahilly, and N. J. Wareham Does Physical Activity Energy Expenditure Explain the Between-Individual Variation in Plasma Leptin Concentrations after Adjusting for Differences in Body Composition? J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3258 - 3263. [Abstract] [Full Text] [PDF]

				M. S. Sandhu, J. M. Gibson, A. H. Heald, D. B. Dunger, and N. J. Wareham Low Circulating IGF-II Concentrations Predict Weight Gain and Obesity in Humans Diabetes, June 1, 2003; 52(6): 1403 - 1408. [Abstract] [Full Text] [PDF]

				C.-C. C. Hung, I. S. Farooqi, K. Ong, J.'a. Luan, J. M. Keogh, M. Pembrey, G. S.H. Yeo, D. Dunger, N. J. Wareham, and S. O' Rahilly Contribution of Variants in the Small Heterodimer Partner Gene to Birthweight, Adiposity, and Insulin Levels: Mutational Analysis and Association Studies in Multiple Populations Diabetes, May 1, 2003; 52(5): 1288 - 1291. [Abstract] [Full Text] [PDF]

				S. Bhattacharyya, J.'a. Luan, B. Challis, C. Schmitz, P. Clarkson, P. W. Franks, R. Middelberg, J. Keogh, I. S. Farooqi, C. Montague, et al. Association of Polymorphisms in GPR10, the Gene Encoding the Prolactin-Releasing Peptide Receptor With Blood Pressure, but not Obesity, in a U.K. Caucasian Population Diabetes, May 1, 2003; 52(5): 1296 - 1299. [Abstract] [Full Text] [PDF]

				R. S. Lindsay, J. D. Walker, I. Halsall, C. N. Hales, A. A. Calder, B. A. Hamilton, and F. D. Johnstone Insulin and Insulin Propeptides at Birth in Offspring of Diabetic Mothers J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1664 - 1671. [Abstract] [Full Text] [PDF]

				M. R. Denburg, M. E. Silfen, A. M. Manibo, D. Chin, L. S. Levine, M. Ferin, D. J. McMahon, C. Go, and S. E. Oberfield Insulin Sensitivity and the Insulin-Like Growth Factor System in Prepubertal Boys with Premature Adrenarche J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5604 - 5609. [Abstract] [Full Text] [PDF]

				D. Chin, S. E. Oberfield, M. E. Silfen, D. J. McMahon, A. M. Manibo, D. Accili, and L. S. Levine Proinsulin in Girls: Relationship to Obesity, Hyperinsulinemia, and Puberty J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4673 - 4677. [Abstract] [Full Text] [PDF]

				A. J.G. Hanley, R. D'Agostino Jr., L. E. Wagenknecht, M. F. Saad, P. J. Savage, R. Bergman, and S. M. Haffner Increased Proinsulin Levels and Decreased Acute Insulin Response Independently Predict the Incidence of Type 2 Diabetes in the Insulin Resistance Atherosclerosis Study Diabetes, April 1, 2002; 51(4): 1263 - 1270. [Abstract] [Full Text] [PDF]

				N. J Wareham, R. W Jakes, K. L Rennie, J. Mitchell, S. Hennings, and N. E Day Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire Int. J. Epidemiol., February 1, 2002; 31(1): 168 - 174. [Abstract] [Full Text] [PDF]

				A. J. G. Hanley, G. McKeown-Eyssen, S. B. Harris, R. A. Hegele, T. M. S. Wolever, J. Kwan, and B. Zinman Cross-Sectional and Prospective Associations between Abdominal Adiposity and Proinsulin Concentration J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 77 - 83. [Abstract] [Full Text] [PDF]

				A. Meirhaeghe, J.'a. Luan, P. Selberg-Franks, S. Hennings, J. Mitchell, D. Halsall, S. O'Rahilly, and N. J. Wareham The Effect of the Gly16Arg Polymorphism of the {beta}2-Adrenergic Receptor Gene on Plasma Free Fatty Acid Levels Is Modulated by Physical Activity J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5881 - 5887. [Abstract] [Full Text] [PDF]

				P. Maison, C. D. Byrne, C. N. Hales, N. E. Day, and N. J. Wareham Do Different Dimensions of the Metabolic Syndrome Change Together Over Time?: Evidence supporting obesity as the central feature Diabetes Care, October 1, 2001; 24(10): 1758 - 1763. [Abstract] [Full Text] [PDF]

				J.'a. Luan, P. O. Browne, A.-H. Harding, D. J. Halsall, S. O’Rahilly, V.K. K. Chatterjee, and N. J. Wareham Evidence for Gene-Nutrient Interaction at the PPAR{gamma} Locus Diabetes, March 1, 2001; 50(3): 686 - 689. [Abstract] [Full Text]

				N. J Wareham, M.-Y. Wong, S. Hennings, J. Mitchell, K. Rennie, K. Cruickshank, and N. E Day Quantifying the association between habitual energy expenditure and blood pressure Int. J. Epidemiol., August 1, 2000; 29(4): 655 - 660. [Abstract] [Full Text] [PDF]

				N. J. Wareham, M.-Y. Wong, and N. E. Day Glucose Intolerance and Physical Inactivity: The Relative Importance of Low Habitual Energy Expenditure and Cardiorespiratory Fitness Am. J. Epidemiol., July 15, 2000; 152(2): 132 - 139. [Abstract] [Full Text] [PDF]

				B. Zethelius, L. Byberg, C. N. Hales, H. Lithell, and C. Berne Proinsulin Is an Independent Predictor of Coronary Heart Disease: Report From a 27-Year Follow-Up Study Circulation, May 7, 2002; 105(18): 2153 - 2158. [Abstract] [Full Text] [PDF]